QVAR (beclomethasone dipropionate hydrofluoroalkane inhalation) / Teva 
Welcome,         Profile    Billing    Logout  
 30 Diseases   6 Trials   6 Trials   148 News 


12»
  • ||||||||||  QVAR (beclomethasone dipropionate hydrofluoroalkane inhalation) / Teva
    Journal:  Extreme return connectedness between renewable energy tokens and renewable energy stock markets: evidence from a quantile-based analysis. (Pubmed Central) -  Jan 22, 2024   
    In the study, return connectedness between assets is investigated with the QVAR model...The return connectedness between these assets is affected by extreme events such as COVID-19, the Russia-Ukraine war, and the collapse of the cryptocurrency market. Since the net return spillover relationships between assets are time-varying and under different market conditions, investors and portfolio managers should constantly review the net return spillovers between assets and adjust their positions accordingly.
  • ||||||||||  QVAR (beclomethasone dipropionate hydrofluoroalkane inhalation) / Teva
    Journal:  Scrutinizing interlinkages between digitalization, economic complexity, green technologies, green energy consumption and CO emission by quantile spillovers in Vietnam. (Pubmed Central) -  Jul 17, 2023   
    We use quantile vector autoregression (QVAR) to identify the connection between six variables related to digitalization (proxied by a number of Internet users and mobile cellular subscriptions), green technology development, green energy consumption, carbon dioxide emissions, and economic complexity index from 1996 to 2019 in Vietnam...In the short term, there was volatility, especially from 2009 to 2013, due to unprecedented events like destructive changes in political, economic, and financial issues in the globe. Our findings are critical for economists and policymakers in promoting a country's digitalization, green technology performance, and green energy on the path toward sustainable development.
  • ||||||||||  Asmanex Twisthaler (mometasone furoate) / Merck (MSD), QVAR (beclomethasone dipropionate hydrofluoroalkane inhalation) / Teva
    Journal:  Using Filters to Estimate Regional Lung Deposition with Pressurized Metered Dose Inhalers. (Pubmed Central) -  Nov 10, 2022   
    The direct measurement of estimated regional deposition is possible when using the FBA. This method is far less resource intensive than existing methods and so may be useful both for comparison of generic alternatives and the development of innovative products.
  • ||||||||||  Ventolin (albuterol) / GSK, QVAR (beclomethasone dipropionate hydrofluoroalkane inhalation) / Teva
    Journal:  Two-way coupling and Kolmogorov scales on inhaler spray plume evolutions from Ventolin, ProAir, and Qvar. (Pubmed Central) -  Sep 28, 2022   
    For the three inhalers considered (Ventolin, ProAir, and Qvar), significant differences were predicted using two-way and one-way coupling despite the level and manifestation of these differences varied. Two-way coupling effects were significant for MDI sprays and should be considered in future numerical studies.
  • ||||||||||  QVAR (beclomethasone dipropionate hydrofluoroalkane inhalation) / Teva
    Journal, PD(L)-1 Biomarker, IO biomarker:  Prediction of Adrenocortical Carcinoma Relapse and Prognosis with a Set of Novel Multigene Panels. (Pubmed Central) -  Jun 11, 2022   
    Sig27var25 and SigIQvar8 were derived from a prostate cancer (PC) and clear cell renal cell carcinoma (ccRCC) multigene signature, respectively; SigCmbnvar5 and SigCmbn_B are combinations of both panels, revealing close relationships of ACC with PC and ccRCC. The origin of these four panels from PC and ccRCC favors their prognostic potential towards ACC.
  • ||||||||||  QVAR (beclomethasone dipropionate hydrofluoroalkane inhalation) / Teva
    Abnormal 129Xe Ventilation MRI and Inhaled Corticosteroid Deposition in Severe Asthma (Room 2009/2011 (West Building, Level 2), Moscone Center) -  Feb 19, 2022 - Abstract #ATS2022ATS_2473;    
    In this small, proof-of-concept study, severe asthmatics with greater ventilation abnormalities observed by MRI (i.e., higher MRIVDP) had higher peripheral and lower central ICS deposition, irrespective of particle size.1J.W.DeBacker et al.Radiology.257(3): 854-62.2M.Kirbyetal.AcadRadiol.2012;19(2): 141-152. 3R.Eddyetal.ERJ.2018;51(6): 1800324
  • ||||||||||  QVAR (beclomethasone dipropionate hydrofluoroalkane inhalation) / Teva
    Journal:  Prevalence of asthma at a school-based health clinic in Nicaragua. (Pubmed Central) -  Aug 22, 2021   
    This study demonstrated the prevalence of asthma in school-aged children in Nicaragua is significant and higher than previously reported. The lack of a classification of asthma prevents patients from potentially being treated appropriately.
  • ||||||||||  Xolair (omalizumab) / Roche, Novartis, Onbrez (indacaterol) / Novartis
    Journal:  Drugs for asthma. (Pubmed Central) -  Jan 26, 2021   
    The lack of a classification of asthma prevents patients from potentially being treated appropriately. No abstract available
  • ||||||||||  Seebri Breezhaler (glycopyrronium bromide) / Novartis, Vectura, Sosei
    Journal:  Drugs for COPD. (Pubmed Central) -  Dec 30, 2020   
    No abstract available No abstract available
  • ||||||||||  QVAR (beclomethasone dipropionate hydrofluoroalkane inhalation) / Teva
    Journal:  Bioavailability of Beclometasone From Two HFA-BDP Formulations With a Spacer. (Pubmed Central) -  Jul 31, 2020   
    No abstract available The difference in the BDP particle size between formulations as well as spacer size greatly affected drug deposition in different regions of the respiratory tract.
  • ||||||||||  [VIRTUAL] In vitro fine particle dose of drug formulation used in asthma & COPD (Pre-congress content) -  Jul 15, 2020 - Abstract #ERS2020ERS_2540;    
    Mean FPD (μg ± standard deviation) FPD from the pMDI with VHC was equivalent or greater than pMDI alone. Although the 4 bronchodilator drug formulations delivered the same drug (SALB) the FPD differed by up to a factor of 2.
  • ||||||||||  Preclinical, Journal:  An Exploration of Factors Affecting In Vitro Deposition of Pharmaceutical Aerosols in the Alberta Idealized Throat. (Pubmed Central) -  Jun 26, 2020   
    Three pressurized metered-dose inhalers (pMDIs; QVAR, Ventolin Evohaler, and Flovent HFA) were examined considering the joint effects of insertion angle (as above) and relative humidity at low (15%-25%) and high (>95%) conditions...When oriented toward the back of the oral cavity, the filter dose decreased from 46.5% to 36.9% for Ventolin Evohaler (p = 0.005) and from 56.7% to 44.2% for Flovent HFA (p < 0.001) at high humidity relative to low. High humidity may cause a reduction in total in vitro lung doses for some pMDI aerosols.
  • ||||||||||  QVAR (beclomethasone dipropionate hydrofluoroalkane inhalation) / Teva
    Journal:  Is "Slow Inhalation" Always Suitable for Pressurized Metered Dose Inhaler? (Pubmed Central) -  Jun 8, 2020   
    Sultanol inhaler (drug particles suspended in a propellant, suspension-pMDI) and QVAR™ (drug dissolved in a propellant with ethanol, solution-pMDI) were used as model pMDIs...Although "slow inhalation" is recommended for pMDIs, airway drug deposition via solution-pMDI (extra-fine particles) is independent of patients' inhalation flow pattern. Clinical studies should be performed to validate instruction for use of pMDIs for each inhaler for the optimization of inhalation therapy.
  • ||||||||||  BDP HFA nasal aerosol (beclomethasone dipropionate hydrofluoroalkane) / Teva, QVAR (beclomethasone dipropionate hydrofluoroalkane inhalation) / Teva
    Journal:  Qvar for Treatment of Chronic Asthma. (Pubmed Central) -  Jun 22, 2019   
    This dose-ranging study demonstrated that the BDP 400 µg TDD appears to offer the optimal efficacy/safety balance to include in the extrafine single-inhaler tripe therapy BDP/FF/G pMDI. No abstract available
  • ||||||||||  QVAR (beclomethasone dipropionate hydrofluoroalkane inhalation) / Teva
    Uncovering increased invasiveness of the Klebsiella oxytoca group () -  Apr 5, 2019 - Abstract #ECCMID2019ECCMID_1894;    
    occur in clinical samples and can be distinguished using MALDI-TOF MS. We found important differences in antibiotic resistance and virulence in-between various Klebsiella groups and species.
  • ||||||||||  QVAR (beclomethasone dipropionate hydrofluoroalkane inhalation) / Teva
    Enrollment change, Trial termination:  Effect of Inhaled Steroids on Gene Expression in the Lungs - 2 (clinicaltrials.gov) -  Jan 25, 2018   
    P4,  N=24, Terminated, 
    We found important differences in antibiotic resistance and virulence in-between various Klebsiella groups and species. N=60 --> 24 | Completed --> Terminated; Funding
  • ||||||||||  QVAR (beclomethasone dipropionate hydrofluoroalkane inhalation) / Teva
    Trial completion, Enrollment change, Trial initiation date:  A Comparison of Beclomethasone Aqueous Spray and Aerosol Delivery Systems in Nasal Polyps (clinicaltrials.gov) -  Aug 28, 2017   
    P2,  N=30, Completed, 
    N=60 --> 24 | Completed --> Terminated; Funding Recruiting --> Completed | N=60 --> 30 | Initiation date: Mar 2008 --> Nov 2006
  • ||||||||||  QVAR (beclomethasone dipropionate hydrofluoroalkane inhalation) / Teva
    Trial completion:  OLiVIA: Effects of QVAR in Smokers With Asthma (clinicaltrials.gov) -  Aug 26, 2016   
    P4,  N=40, Completed, 
    Recruiting --> Completed | N=290 --> 360 | Initiation date: Dec 2014 --> May 2014 Recruiting --> Completed
  • ||||||||||  QVAR (beclomethasone dipropionate hydrofluoroalkane inhalation) / Teva
    Trial completion, Trial primary completion date:  Effect of Inhaled Steroids on Gene Expression in the Lungs - 2 (clinicaltrials.gov) -  May 3, 2016   
    P4,  N=60, Completed, 
    Recruiting --> Completed Active, not recruiting --> Completed | Trial primary completion date: Jul 2015 --> Jan 2015
  • ||||||||||  QVAR (beclomethasone dipropionate hydrofluoroalkane inhalation) / Teva
    Enrollment open:  OLiVIA: Effects of QVAR in Smokers With Asthma (clinicaltrials.gov) -  Jun 18, 2014   
    P4,  N=40, Recruiting, 
    N=62 --> 7 Not yet recruiting --> Recruiting
  • ||||||||||  QVAR (beclomethasone dipropionate hydrofluoroalkane inhalation) / Teva
    Enrollment closed:  Effect of Inhaled Steroids on Gene Expression in the Lungs - 2 (clinicaltrials.gov) -  Jun 12, 2014   
    P4,  N=60, Active, not recruiting, 
    Not yet recruiting --> Recruiting Recruiting --> Active, not recruiting
  • ||||||||||  rosiglitazone / Generic mfg.
    Trial completion:  Rosiglitazone Versus Theophylline in Asthmatic Smokers (clinicaltrials.gov) -  Feb 22, 2014   
    P2/3,  N=79, Completed, 
    Recruiting --> Active, not recruiting No longer recruiting --> Completed
  • ||||||||||  QVAR (beclomethasone dipropionate hydrofluoroalkane inhalation) / Teva
    Trial completion:  Early Diagnosis of Asthma in Young Children (clinicaltrials.gov) -  Jun 16, 2013   
    P=N/A,  N=202, Completed, 
    No longer recruiting --> Completed Active, not recruiting --> Completed